Chordate Medical Holding AB
Develops a patented, drug-free neuromodulation treatment for migraine and rhinitis.
CMH | ST
Overview
Corporate Details
- ISIN(s):
- SE0021486131 (+1 more)
- LEI:
- 549300R0GG2J3S0BFN79
- Country:
- Sweden
- Address:
- C/O Regus, 164 40 Kista
- Website:
- https://www.chordate.com/en/
Description
Chordate Medical Holding AB is a medical technology company that has developed and patented Ozilia®, a CE-marked, drug-free neuromodulation treatment. The technology is indicated for the treatment of chronic migraine and chronic rhinitis. Ozilia® provides a non-pharmacological alternative to conventional medications, such as pills or injections, and is associated with minimal side effects. The company's business model is centered on building value through an extensive patent portfolio, clinical studies demonstrating efficacy, and establishing commercial success in selected markets with the goal of a future exit.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Type / Size | Actions | |
|---|---|---|---|---|---|
|
2024-12-15
English
4.2 MB
2024-10-30
German
1.8 MB
2024-08-14
French
0.5 MB
2024-05-22
English
2.1 MB
2024-03-10
English
3.5 MB
2024-01-15
German
1.2 MB
2023-11-20
English
5.1 MB
Full Filing History RestrictedAccess to specific historical documents or filtered results is limited in the Web UI. Request access to the complete dataset. |
|||||
Automate Your Workflow. Get a real-time feed of all Chordate Medical Holding AB filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Chordate Medical Holding AB
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Chordate Medical Holding AB via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2021-10-29 | Niklas Lindecrantz | Other | Other | 25,000 | 18,750.00 SEK |
| 2021-08-23 | Nils Henrik Milton Rammer | Other | Other | 15,000 | 41,100.00 SEK |
| 2021-08-23 | Nils Henrik Milton Rammer | Other | Other | 15,000 | N/A |
| 2021-03-04 | Tommy Hedberg | Other | Buy | 75,000 | 40,103.40 SEK |
Peer Companies
